The pharma major is hopeful of maintaining its revenue growth guidance of 13-15 percent for FY15 though the margins may get impacted marginally.
first published: Nov 14, 2014 11:59 am
A collection of the most-viewed Moneycontrol videos.

A money superpower you have in your 20s, not in 40s

Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell

Live: Will US-Venezuela tensions derail Nifty's upmove? | Oil stocks in focus | Opening Bell

New Year Party Or Year-End Blues? Bulls In Focus| Top Stock Bets & 2026 Outlook| Opening Bell Live
You are already a Moneycontrol Pro user.

